Rxivist logo

Author: Kathrin U. Jansen

  • Most recently observed institution: Pfizer Vaccine Research and Development, Pearl River, NY, USA

Rankings

  • All-time downloads: 451,095 (rank: 61 )
  • Categories:
    • immunology: 73,574 (rank: 89 (tie) )
    • infectious diseases: 376,516 (rank: 44 (tie) )
    • microbiology: 1,005 (rank: 17,557 (tie) )

Downloads per author, site-wide

Preprints

Six Month Safety and Efficacy of the BNT162b2 mRNA COVID-19 Vaccine

infectious diseases more details view paper
  • Downloaded 187,844 times
  • Download rankings, all-time:
    • Site-wide: 24
    • In infectious diseases: 10
  • Year to date:
    • Site-wide: 4
  • Since beginning of last month:
    • Site-wide: 6

RNA-Based COVID-19 Vaccine BNT162b2 Selected for a Pivotal Efficacy Study

infectious diseases more details view paper
  • Downloaded 77,363 times
  • Download rankings, all-time:
    • Site-wide: 86
    • In infectious diseases: 31
  • Year to date:
    • Site-wide: 106
  • Since beginning of last month:
    • Site-wide: 108

Phase 1/2 Study to Describe the Safety and Immunogenicity of a COVID-19 RNA Vaccine Candidate (BNT162b1) in Adults 18 to 55 Years of Age: Interim Report

infectious diseases more details view paper
  • Downloaded 71,207 times
  • Download rankings, all-time:
    • Site-wide: 96
    • In infectious diseases: 37
  • Year to date:
    • Site-wide: 341
  • Since beginning of last month:
    • Site-wide: 597

A prefusion SARS-CoV-2 spike RNA vaccine is highly immunogenic and prevents lung infection in non-human primates

immunology more details view paper
  • Downloaded 70,737 times
  • Download rankings, all-time:
    • Site-wide: 98
    • In immunology: 2
  • Year to date:
    • Site-wide: 40
  • Since beginning of last month:
    • Site-wide: 20

Concurrent human antibody andTH1 type T-cell responses elicited by a COVID-19 RNA vaccine

infectious diseases more details view paper
  • Downloaded 23,930 times
  • Download rankings, all-time:
    • Site-wide: 364
    • In infectious diseases: 135
  • Year to date:
    • Site-wide: 820
  • Since beginning of last month:
    • Site-wide: 3,977

BNT162b2 induces SARS-CoV-2-neutralising antibodies and T cells in humans

infectious diseases more details view paper
  • Downloaded 16,172 times
  • Download rankings, all-time:
    • Site-wide: 551
    • In infectious diseases: 199
  • Year to date:
    • Site-wide: 214
  • Since beginning of last month:
    • Site-wide: 879

BNT162b vaccines are immunogenic and protect non-human primates against SARS-CoV-2

immunology more details view paper
  • Downloaded 2,837 times
  • Download rankings, all-time:
    • Site-wide: 5,660
    • In immunology: 201
  • Year to date:
    • Site-wide: 1,723
  • Since beginning of last month:
    • Site-wide: 6,517

BNT162b2-Elicited Neutralization of Delta Plus, Lambda, and Other Variants

microbiology more details view paper
  • Downloaded 1,005 times
  • Download rankings, all-time:
    • Site-wide: 26,307
    • In microbiology: 1,544
  • Year to date:
    • Site-wide: 4,324
  • Since beginning of last month:
    • Site-wide: 330

PanLingua

News